NDC 0006-5007 – Delstrigo
Doravirine 100 mg/1; Lamivudine 300 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral
Product NDC0006-5007
Product details
- Brand name
- Delstrigo
- Generic name
- Doravirine, lamivudine, and tenofovir disoproxil fumarate
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA210807
- Marketed since
- July 20, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Doravirine 100 mg/1
- Lamivudine 300 mg/1
- Tenofovir Disoproxil Fumarate 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0006-5007-01 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-5007-01) | Jul 20, 2018 |